EcoDrugPlus

Thromboxane A Synthase 1 (Platelet)

Ensembl ID : ENSDLAG00005020842
Gene Symbol: TBXAS1
1 Cross references
220 Possible Orthologues:

Thromboxane A2 Receptor

Ensembl ID : ENSDLAG00005025743
Gene Symbol: TBXA2R
1 Cross references
193 Possible Orthologues:

Thymidylate Synthetase

Ensembl ID : ENSDLAG00005018900
Gene Symbol: TYMS
1 Cross references
225 Possible Orthologues:

Thyrotropin Releasing Hormone Receptor

Ensembl ID : ENSDLAG00005005682
Gene Symbol: TRHR
1 Cross references
203 Possible Orthologues:

Thyrotropin-Releasing Hormone Receptor B

Ensembl ID : ENSDLAG00005011218
Gene Symbol: TRHRB
1 Cross references
194 Possible Orthologues:

Toll Like Receptor 2

Ensembl ID : ENSDLAG00005028401
Gene Symbol: TLR2
1 Cross references
182 Possible Orthologues:

Transforming Growth Factor, Beta Receptor 1 B

Ensembl ID : ENSDLAG00005006166
Gene Symbol: TGFBR1B
1 Cross references
205 Possible Orthologues:

Transient Receptor Potential Cation Channel, Subfamily A, Member 1b

Ensembl ID : ENSDLAG00005000324
Gene Symbol: TRPA1B
1 Cross references
201 Possible Orthologues:

Transthyretin

Ensembl ID : ENSDLAG00005031018
Gene Symbol: TTR
1 Cross references
180 Possible Orthologues:

Tryptophan Hydroxylase 1 (Tryptophan 5-Monooxygenase) A

Ensembl ID : ENSDLAG00005013740
Gene Symbol: TPH1A
1 Cross references
202 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSDLAG00005028556
Gene Symbol: TUBA4A
1 Cross references
102 Possible Orthologues:

Tubulin, Beta 2a Class Iia

Ensembl ID : ENSDLAG00005020323
Gene Symbol: TUBB2
1 Cross references
301 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).